MK-4700
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-4700, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001) [Phase 1]